NATALIE GRAZIANO: Open Payments
NPI 1891402376 · BLOOMFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 43 payments from 12 companies in 2025. Trend: 2023 $740 · 2024 $715 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $186 |
| AstraZeneca Pharmaceuticals LP | 2 | $117 |
| Novo Nordisk Inc | 6 | $92 |
| Lilly USA, LLC | 5 | $90 |
| PFIZER INC. | 4 | $67 |
| Exact Sciences Corporation | 2 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: UBRELVY, AIRSUPRA, Wegovy, MOUNJARO, Cologuard Collection Kit, JARDIANCE, ZORYVE, NURTEC ODT.
Industry payments across NJ — which companies pay providers there.
